NCT03483337

New MRI Biomarkers in Head and Neck Cancers

Quantitative Imaging Tools to Derive DW-MRI Oncological Biomarkers

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor. The purpose of this study is to see if new MRI methods can give us more information about the tumor.

Conditions

• Head and Neck Cancer
• Thyroid Cancer

Interventions

Type	Name	Description
OTHER	MRI examinations	Patients will be imaged on a 1.5 T or 3 T MR scanner either from GE or Philips. Patients will receive a test-retest scan in on session prior to start of treatment. Patients who will be receiving radiation therapy treatment at main campus, will also be imaged weekly during their course of treatment.
OTHER	MRI examinations	Patients will be imaged on a 1.5 T or 3T MR scanner within one week prior to treatment initiation and at two months and four months after treatment completion (+/- 1 week).

Timeline

• Start date: 2018-03-16
• Primary completion: 2027-03-01
• Completion: 2027-03-01
• First posted: 2018-03-30
• Last updated: 2026-04-14

Locations

1 site across 1 country: United States